Measuring thousands of wells in minutes for drug screening
An essential part of the early phase of drug discovery is screening libraries of compounds in order to detect potential ‘hits’ which interact with a therapeutic target. Common targets include membrane proteins such as GPCRs as well as kinases. Compounds acting on a therapeutic target have to be identified out of libraries of thousands to millions of compounds, making automation of the process using microplate readers essential.
Screens are mainly conducted in 384 and 1536 well plates to minimize reaction volumes per sample. Speed and sensitivity are key requirements for screeners. A 1536 well microplate needs to be measured in seconds, maximally a few minutes. Furthermore, the fast measurement of 10 µl or even lower volume samples needs to be very precise and stable to clearly identify hits from a vast number of compounds. In addition, the reader needs to be reliable, as errors occurring during a screen result in repetitions, loss of time, reagents and consequently money.
BMG LATBECH’s multi-mode microplate readers have market leading performance ensuring hits can be reliably detected at low volumes and at the fastest speeds. This not only enables the highest throughput but also allows rapid cycle times in kinetic assays required for studying binding kinetics and on/off rates.
The PHERAstar FSX masters all these requirements in all detection modes, and also meets supports the changing needs of screening facilities, making it popular in screening facilities. For screening assay development and testing, the CLARIOstar Plus is the perfect addition to develop and characterize an assay before transitioning to high throughput.
Take a look at the links below to find out more about our instruments and how they have been used by drug screeners.
Receptors
Resources
Search our resources section for information about specific applications, literature citations, videos, blog articles and many other publications. Many of the resources provided are associated with current and previous instrument models and versions.
Resazurin Cell Viability Assay for the Discovery of Selective Cytotoxic Compounds in Canine Mammary Cancer Research
Snake venom has a very bad image. But it’s not all bad - If you would like to read about the useful functions of snake venoms as an anti-cancer treatment click here.
Differential binding of ∆9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
Looking for alternative acceptor fluorophores in TR-FRET attempts? Read here how CELT-335 was successfully used in a Cannabinoid competition binding assay at CB1.
High-throughput screening and hit validation with a fluorescence polarization assay
Read here, how a fluorescence polarization-based interaction assay on the PHERAstar FSX can be used to reduce sample volumes, cost, and time-requirements for high-throughput screening.
Competition assay using Fluorescence Polarization to determine the Residence Times for Calcitonin and AMYR agonist, AM833
Inform yourself here about the benefits of an alternative to (TR-)FRET-/BRET-based competition assays using FP for the determination of kon and koff of ligand/receptor interaction.
The ‘Advanced Assay Stability’ system facilitates a stable detection environment for temperature-sensitive assays
Difficulties comparing your results due to temperature variations? Read here how the cooling function of the PHERAstar FSX with AAS enables stable temperature and circumvents these problems.
Viral Cytopathic effects measured in a drug discovery screen
Are you looking for a label-free method to study potential antiviral drugs? This AppNote presents a fast and cheap way to study viral cytopathic effects with cell viability/toxicity assays.
Gene reporter assays
Gene reporter assays are sensitive and specific tools to study the regulation of gene expression. Learn about the different options available, their uses, and the benefits of running these types of assays on microplate readers.
Targeted protein degradation and next-generation degraders
Innovation for targeted protein degradation and next-generation degraders is gathering pace. This blog introduces some of the different approaches that act via the lysosome or proteasome.
Cell-based protein degrader assays for microplates
The choice of assay for targeted protein degradation studies is crucial. But what is the preferred assay and detection technology for your specific research needs and microplate reader?
Molecular glues: new solutions for undruggable proteins
Molecular glues are small molecules that help target unwanted proteins for destruction by the ubiquitin-proteasome system. Find out how microplate readers can advance molecular glue research.
Cannabinoid receptor ligands as templates for drug discovery
Cannabinoids offer exciting opportunities to target diverse diseases with unmet needs. Learn how microplate readers can help improve our understanding of drug screening and drug signaling events to help advance cannabinoid research.
PROTACs: proteolysis-targeting chimeras
PROTACs are small, readily designed molecules that target unwanted proteins to the cell’s ubiquitin-proteasome system for degradation. Find out how microplate readers can advance PROTAC research.
Live cell systems for degrader evaluation
Martin Schwalm discusses measuring PROTAC-induced degradation, ternary complex formation kinetics and stability, and shows a complete pipeline using live cells.
Targeting the type 1 cholecystokinin receptor to screen for novel obesity treatments
Development of functional, binding and multiplex assays targeting the type 1 cholecystokinin receptor to screen for potential new compounds against obesity.
Binding affinity determination on microplate readers
Binding affinity is an important parameter in drug discovery. Find out, how microplate readers can be used for binding affinity determination and the advantages they offer.
Using the TRUPATH BRET platform to analyse GPCR biased agonism
TRUPATH is a BRET-based platform that enables to monitor discrete GPCR-G protein coupling and can facilitate the discovery of drugs biased towards desired G protein effectors.
Current microplate-based interaction assays for drug discovery
Protein-protein interaction is the key in physiological processes - and likewise many diseases. Learn here about possible approaches to study interactions in drug screening using NanoBRET and TR-FRET.
Kinetics in Drug Discovery
Martin Redhead, group leader at UCB, discusses the use and impact of kinetic binding methods across the drug discovery pipeline.
Building a bridge between organoid research and drug discovery
Elad Katz founder of Navigate Precision Biology established a 384-well based organoid platform and runs his assays with the PHERAstar.
The benefits of studying opioid, cannabinoid, terpenoid, and 5HT receptor agonists
Dr Marina Junqueira Santiago discusses the potential benefits of studying opioid, cannabinoid, terpenoid, and 5HT receptor agonists.
Targeted protein degradation – next-generation therapeutics
Helen Harrison, Director of Screening at Amphista Therapeutics, discusses targeted protein degradation and the discovery of drugs in this area.
Taking a wholistic approach to automation
Mathew Keegan talks about the seamless integration of BMG LABTECH plate readers into Automata´s system
From assay development to compound screening
Joao used a CLARIOstar Plus and a PHERAstar FSX, for assay development and compound screening against a viral exonuclease.
Simplifying laboratory automation
David Reed (Managing Director at Flexible Lab Solutions) talks about the seamless integration of the BMG LABTECH microplate reader PHERAstar FSX into this system.
PHERAstar FSX
Powerful and most sensitive HTS plate reader
CLARIOstar Plus
Most flexible Plate Reader for Assay Development
NEPHELOstar Plus
Microplate nephelometer for light-scattering and turbidity measurements